Taken together, regardless of the relative importance of each of these factors (reduced ROS generation, increased ATP resynthesis, and vasodilatation), all of the DPP-4 inhibitor-caused changes are compatible with our understanding of their protective effects against ventricular arrhythmias. Here, DPP4 is linked to Ventricular arrhythmia.